All products
By area
By ATC classifier
! Pharmacovigilance

DUGLIMAX tablets

The active substance:


Indications for use:

As an adjunct to diet and exercise for patients with insulin-independent type 2 diabetes mellitus:

  • if metformin or sulfonylureas monotherapy does not provide an adequate level of glycemic control;
  • shifting from combination therapy to metformin and sulfonylureas.

1 tablet contains metformin hydrochloride (long-acting) 500 mg and glimepiride 1 mg or metformin hydrochloride (long-acting) 500 mg and glimepiride 2 mg; Antidiabetic drugs. The combination of oral hypoglycemic drugs.

For detailed information, please see instruction for medical use.